Market Overview

Research and Markets: Global Non-hodgkin's Lymphoma Drug Pipeline Capsule - 2012 Update

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets has announced the addition of the "Global Non-hodgkin's Lymphoma Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Non-hodgkin's Lymphoma Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Non-hodgkin's Lymphoma market. It covers active Non-hodgkin's Lymphoma pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Non-hodgkin's Lymphoma - Disease Overview

2. Non-hodgkin's Lymphoma Pipeline Overview

3. Non-hodgkin's Lymphoma Phase 3 Clinical Trial Pipeline Insights

4. Non-hodgkin's Lymphoma Phase 2 Clinical Trial Pipeline Insights

5. Non-hodgkin's Lymphoma Phase 1 Clinical Trial Pipeline Insights

6. Non-hodgkin's Lymphoma Preclinical Research Pipeline Insights

7. Non-hodgkin's Lymphoma Discovery Stage Pipeline Insights

8. Non-hodgkin's Lymphoma Drug Development Activities - Geographic Landscape

8.1. Non-hodgkin's Lymphoma R&D Activities in North America

8.2. Non-hodgkin's Lymphoma R&D Activities in Europe

9. Non-hodgkin's Lymphoma Pipeline - Licensing Activities

Table 1. Non-hodgkin's Lymphoma Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Non-hodgkin's Lymphoma Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Non-hodgkin's Lymphoma Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Non-hodgkin's Lymphoma Pipeline Molecules - Preclinical Research

Table 5. Non-hodgkin's Lymphoma Pipeline Molecules - Drug Discovery

Table 6. Non-hodgkin's Lymphoma R&D Activities by Geography

Table 7. Non-hodgkin's Lymphoma Pipeline Molecules - North America

Table 8. Non-hodgkin's Lymphoma Pipeline Molecules - Europe

Table 9. Non-hodgkin's Lymphoma Pipeline - Licensing Activities

Figure 1. Non-hodgkin's Lymphoma Pipeline Molecules by R&D Stage

Figure 2. Non-hodgkin's Lymphoma R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/qzxflh/global

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free